Cite
Elevated serum soluble Fas ligand in natural killer cell proliferative disorders
MLA
K, Kato, et al. “Elevated Serum Soluble Fas Ligand in Natural Killer Cell Proliferative Disorders.” British Journal of Haematology, vol. 103, no. 4, Jan. 1999. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........5ee20d86ac678abaa60ad85220478260&authtype=sso&custid=ns315887.
APA
K, K., K, O., S, I., K, A., J, S., & M, K. (1999). Elevated serum soluble Fas ligand in natural killer cell proliferative disorders. British Journal of Haematology, 103(4).
Chicago
K, Kato, Ohshima K, Ishihara S, Anzai K, Suzumiya J, and Kikuchi M. 1999. “Elevated Serum Soluble Fas Ligand in Natural Killer Cell Proliferative Disorders.” British Journal of Haematology 103 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........5ee20d86ac678abaa60ad85220478260&authtype=sso&custid=ns315887.